BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 18703276)

  • 41. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
    Sun L; Chen W; Qu L; Wu J; Si J
    Mol Med Rep; 2013 Dec; 8(6):1883-7. PubMed ID: 24145579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
    Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
    Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor].
    Song XR; Hou SX
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1300-4. PubMed ID: 16245913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins?
    Shatz M; Liscovitch M
    Leuk Res; 2004 Sep; 28(9):907-8. PubMed ID: 15234566
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.